What Experts Say About Hims & Hers’ $1.15B Acquisition of Eucalyptus
Experts say Hims & Hers’ acquisition of Eucalyptus positions the company for global expansion and revenue diversification amid U.S. GLP-1 regulatory challenges. The post What
Experts say Hims & Hers’ acquisition of Eucalyptus positions the company for global expansion and revenue diversification amid U.S. GLP-1 regulatory challenges. The post What
At the end of the day, it doesn’t matter what your patient mix looks like; your notes can and will be pulled into audits. Waiting
Korsana Biosciences’ preclinical Alzheimer’s disease drug comes from a platform technology that enables antibodies to cross the blood-brain barrier. Roche and AbbVie have clinical-stage drugs
Shalin Shah, CEO of Marius Pharmaceuticals, which makes an oral testosterone replacement drug, thinks TRT therapy should no longer be regulated as a controlled substance
Early experience and comfort with AI benefits everyone. Nurses who understand how to work alongside technology are better equipped to deliver high-quality care, adapt to
Since adopting Arintra’s AI platform for medical coding in 2023, Mercyhealth has seen a 5.1% rise in revenue and a 50% decline in its days
HealthGility provides healthcare organizations with a solution for patient protected health information disclosure and confidentiality that reduces workloads and ensures the safe and secure sharing of sensitive data between different providers.